Award
National Cancer Institute 5R01CA281286-03
Neoadjuvant immunoradiotherapy for HPV mediated oropharynx cancer
Recipient
University of California, San Diego
Award Amount
$619,487.00
Ceiling
$619,487.00
Awarded
July 17, 2025
Identifier
5R01CA281286-03
Award for clinical research on neoadjuvant immunoradiotherapy for HPV-mediated oropharynx cancer to evaluate safety, efficacy, and immune response of combined SBRT and immunotherapy.
Description
This project involves clinical research on neoadjuvant immunoradiotherapy for HPV-related oropharynx cancer, funded by the NIH/NCI. The project aims to evaluate the safety, efficacy, and immune response of combined SBRT and immunotherapy treatments.